Human LCAT protein (Recombinant) (C-His) (STJP013089)
SPECIFICATIONS
HostMammalian Cells
ConjugationUnconjugated
ImmunogenHomo sapiens (Human)
General Information
| Short Description | Recombinant-Human LCAT-C-His protein was developed from mammalian cells and has a target region of C-His. For use in research applications. |
| Applications | ELISA/WB |
| Host | Mammalian Cells |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Dilution Range | Reconstitute in sterile water for a stock solution. |
| Formulation | Lyophilized from a 0.22 Mu m filtered solution in 4mM HCl. |
| Storage Instruction | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at-20 to-80°C for twelve months from the date of receipt. |
| Endotoxin | < 1 EU/µg as determined by LAL test. |
Target Information
| Gene Symbol | LCAT |
| Gene ID | 3931 |
| Uniprot ID | LCAT_HUMAN |
| Immunogen | Homo sapiens (Human) |
| Immunogen Region | Phe25-Glu440 |
Additional Info
| Post Translational Modifications | O- and N-glycosylated. O-glycosylation on Thr-431 and Ser-433 consists of sialylated galactose beta 1-->3N-acetylgalactosamine structures. N-glycosylated sites contain sialylated triantennary and/or biantennary complex structures. |
| Function | Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs). The cholesterol ester is then transported back to the liver. Has a preference for plasma 16:0-18:2 or 18:O-18:2 phosphatidylcholines. Also produced in the brain by primary astrocytes, and esterifies free cholesterol on nascent APOE-containing lipoproteins secreted from glia and influences cerebral spinal fluid (CSF) APOE- and APOA1 levels. Together with APOE and the cholesterol transporter ABCA1, plays a key role in the maturation of glial-derived, nascent lipoproteins. Required for remodeling high-density lipoprotein particles into their spherical forms. Catalyzes the hydrolysis of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor or PAF) to 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF). Also catalyzes the transfer of the acetate group from PAF to 1-hexadecanoyl-sn-glycero-3-phosphocholine forming lyso-PAF. Catalyzes the esterification of (24S)-hydroxycholesterol (24(S)OH-C), also known as cerebrosterol to produce 24(S)OH-C monoesters. |
| Protein Name | Phosphatidylcholine-Sterol Acyltransferase1-Alkyl-2-Acetylglycerophosphocholine EsteraseLecithin-Cholesterol AcyltransferasePhospholipid-Cholesterol AcyltransferasePlatelet-Activating Factor AcetylhydrolasePaf Acetylhydrolase |
| Database Links | Reactome: R-HSA-8964058 |
| Cellular Localisation | SecretedSecreted Into Blood PlasmaProduced In Astrocytes And Secreted Into Cerebral Spinal Fluid (Csf) |
| Alternative Protein Names | Phosphatidylcholine-Sterol Acyltransferase protein1-Alkyl-2-Acetylglycerophosphocholine Esterase proteinLecithin-Cholesterol Acyltransferase proteinPhospholipid-Cholesterol Acyltransferase proteinPlatelet-Activating Factor Acetylhydrolase proteinPaf Acetylhydrolase proteinLCAT protein |
Information sourced from Uniprot.org